Related Experiment Video
Updated: Feb 13, 2026

09:52
Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
11.1K
Eosinophils in fungal diseases: An overview
Rodrigo T Figueiredo1, Josiane S Neves2
1Institute of Biomedical Sciences/Unit of Xerem, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Journal of Leukocyte Biology
|March 10, 2018
Summary
Eosinophils play key roles in allergic asthma and allergic bronchopulmonary mycosis (ABPMs). This review explores eosinophil-fungal interactions and their therapeutic potential in lung diseases.
Area of Science:
- Immunology
- Pulmonology
- Mycology
Background:
- Eosinophils are central to allergic asthma and allergic bronchopulmonary mycosis (ABPMs).
- The precise roles of eosinophils in the immunopathology of these conditions are not fully elucidated.
- Mechanisms of direct molecular interactions between fungi and eosinophils remain largely unknown.
Purpose of the Study:
- To provide an overview of eosinophil contributions to allergic asthma and ABPMs.
- To revise mechanisms of fungal recognition by eosinophils.
- To examine advances in understanding eosinophil innate effector responses to fungi and their therapeutic relevance.
Main Methods:
- Literature review and synthesis of existing research.
- Analysis of immunological mechanisms of eosinophil-fungal interactions.
- Examination of therapeutic implications for fungal-associated allergic lung diseases.
Main Results:
- Eosinophils are significant effector cells in fungal-associated allergic airway diseases.
- General mechanisms of fungal recognition by eosinophils are outlined.
- Specific molecular interactions between eosinophils and fungi like Alternaria alternata, Candida albicans, and Aspergillus fumigatus are discussed.
Conclusions:
- Understanding eosinophil-fungal interactions is crucial for elucidating the immunopathology of ABPMs and related asthma.
- Further research into these molecular mechanisms may reveal novel therapeutic targets.
- Targeting eosinophil responses holds promise for treating fungus-associated allergic pulmonary diseases.
Related Concept Videos
Parkinson's Disease: Overview
2.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.1K
Alzheimer's Disease: Overview
1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K
Ischemic Heart Disease: Overview
3.5K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.5K
Fungal Group Zygomycota
1.4K
Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
1.4K
Fungal Phylum Microsporidia
567
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
567
Fungal Phylum Ascomycota
1.5K
Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
1.5K

